Sequenom Inc (SQNM)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
MEASURING & CONTROLLING DEVICES, NEC
CEO:
Dirk van den Boom
Employees:
434
3595 JOHN HOPKINS COURT, SAN DIEGO, X1 92121
8582029000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women's health and oncology markets in the United States and internationally.

Data derived from most recent annual or quarterly report
Market Cap 284.936 Million Shares Outstanding119.22 Million Avg 30-day Volume 1.779 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from SQNM instead.

View recent insider trading info

Funds Holding SQNM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SQNM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LABORATORY CORP OF AMERICA HOLDINGS

  • 10% Owner
119,551,297 2016-09-07 0

LAI GOLDMAN MYLA

  • Director
No longer subject to file 2016-09-07 0

LINTON JEFFREY D SR VP, GC & SECRETARY

  • Officer
No longer subject to file 2016-09-07 0

PENDARVIS DAVID

  • Director
No longer subject to file 2016-09-07 0

SLACIK CHARLES P

  • Director
No longer subject to file 2016-09-07 0

EISENBERG GLENN A EVP AND TREASURER

  • Officer
  • Director
0 2016-09-07 0

EBERTS F SAMUEL III CHAIRMAN, PRESIDENT & SEC

  • Officer
  • Director
0 2016-09-07 0

BUECHLER KENNETH F

  • Director
No longer subject to file 2016-09-07 0

LINDSAY RONALD M

  • Director
No longer subject to file 2016-09-07 0

HAAS WILLIAM

  • Director
0 2016-09-07 0

LERNER RICHARD A

  • Director
No longer subject to file 2016-09-07 0

MILLER BENJAMIN R

  • Director
0 2016-09-07 0

BEAVER CAROLYN SVP & CFO

  • Officer
No longer subject to file 2016-09-07 0

VAN DEN BOOM DIRK PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2016-09-07 0

WEINER ROBIN SVP CORP GOV & REG AFFAIRS

  • Officer
No longer subject to file 2016-09-07 0

VAN DER VAART SANDRA D

  • Director
0 2016-09-07 0

GROSU DANIEL S MD SVP & CMO

  • Officer
No longer subject to file 2016-09-07 0

MACKEY CATHERINE J

  • Director
No longer subject to file 2016-09-07 0

LOZUK ROBERT SVP, COMMERCIAL OPS

  • Officer
No longer subject to file 2016-09-07 0

CAMBER CAPITAL MANAGEMENT LLC

  • 10% Owner
17,325,000 2015-12-30 0

WELCH WILLIAM J PRESIDENT & CEO

  • Officer
56,060 2015-06-10 0

HIXSON HARRY F JR

  • Director
283,794 2015-02-10 0

FAZIO JOHN A

  • Director
0 2014-06-10 0

MONKO ALEXANDER MICHAEL SR. VP, GENETIC ANALYSIS

  • Officer
No longer subject to file 2014-05-30 0

MAIER PAUL V CHIEF FINANCIAL OFFICER

  • Officer
73,789 2014-02-10 0

BOWEN R WILLIAM SR. VP AND GENERAL COUNSEL

  • Officer
21,337 2014-02-10 0

BOMBARD ALLAN CHIEF MEDICAL OFFICER

  • Officer
52,728 2014-02-10 0

CANTOR CHARLES R CHIEF SCIENTIFIC OFFICER

  • Officer
165,663 2013-06-19 0

JUDGE ALISA VP, HUMAN RESOURCES

  • Officer
7,765 2013-06-19 0

AFTING ERNST-GUENTER

  • Director
0 2013-06-11 0

NEUMANN CLARKE VP & GENERAL COUNSEL

  • Officer
21,907 2012-02-07 0

MYRES LARRY VP, OPERATIONS

  • Officer
4,996 2011-07-18 0

ZIMMERMAN JOSEPH VP & GENERAL MANAGER, SCMM

  • Officer
0 2010-08-03 0

KARSTEN SCHMIDT VP, BUSINESS DEVELOPMENT

  • Officer
25,569 2010-02-09 0

WILTSEY KATHLEEN M

  • Director
0 2010-01-04 0

MARCELL SHAWN M VP, MOLECULAR DIAG, ONCOL

  • Officer
31,243 2009-12-23 0

FILE JUSTIN J PRINCIPAL ACCTG & FNCL OFCR

  • Officer
1,136 2009-09-28 0

RIDGEBACK CAPITAL INVESTMENTS L.P.

RIDGEBACK CAPITAL INVESTMENTS LTD.

RIDGEBACK CAPITAL MANAGEMENT LLC

  • 10% Owner
No longer subject to file 2009-04-29 0

OWINGS STEVE VP OPS, PRENATAL DIAGNOSTICS

  • Officer
0 2009-03-24 0

HAWRAN PAUL W CHIEF FINANCIAL OFFICER

  • Officer
115,888 2009-03-13 0

STYLLI HARRY PRESIDENT AND CEO

  • Officer
  • Director
142,511 2009-03-13 0

DRAGON ELIZABETH SR VP, RESEARCH & DEVELOPMENT

  • Officer
0 2009-02-09 0

TATMAN DERECK VP, BUSINESS DEVELOPMENT

  • Officer
0 2009-02-09 0

RIORDAN GARY VP, REG AFFAIRS & QUALITY

  • Officer
0 2009-01-16 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL BIOTECH FUND LP

RA CAPITAL BIOTECH FUND II, L.P.

KOLCHINSKY PETER

ALDRICH RICHARD

  • 10% Owner
5,872,966 2008-07-10 0

LEHMAN BROTHERS HOLDINGS INC

  • 10% Owner
No longer subject to file 2008-06-10 0

SIEMENS VENTURE CAPITAL GMBH

SIEMENS AKTIENGESELLSCHAFT

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2007-12-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments